Matrix metalloproteinase 3 haplotypes and dementia and Alzheimer's disease - The Rotterdam Study

被引:7
作者
Reitz, Christiane [1 ]
van Rooij, Frank J. A. [1 ]
de Maat, Moniek P. M. [3 ]
den Heijer, Tom [1 ,2 ]
Hofman, Albert [1 ]
Witteman, Jacqueline C. M. [1 ]
Breteler, Monique M. B. [1 ]
机构
[1] Erasmus MC, Dept Epidemiol & Biostat, NL-3000 DR Rotterdam, Netherlands
[2] Erasmus MC, Dept Neurol, NL-3000 DR Rotterdam, Netherlands
[3] Erasmus MC, Dept Hematol, NL-3000 DR Rotterdam, Netherlands
关键词
matrix metalloproteinase 3; polymorphism; haplotypes; dementia; Alzheimer's disease; hippocampus; white matter lesions;
D O I
10.1016/j.neurobiolaging.2007.01.001
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Evidence by post-mortem and animal studies suggests that matrix metalloprotemases (MMPs) may play an important role in the pathophysiology of Alzheimer's disease (AD) through degradation of amyloid beta. We investigated in 5999 elderly whether MMP3-haplotypes are associated with cognitive performance over time, dementia and AD. We also explored the association of MMP-3 haplotypes with changes in hippocampal volume and severity of periventricular and subcortical white matter lesions (WML). There was no association between any individual polymorphism or MMP-3 haplotypes and performance in MMSE over time, dementia or AD, and there was no association between MMP-3 genotypes or haplotypes with hippocampal volume or severity of periventricular or subcortical WML. These associations did not differ between strata of APOE epsilon 4 genotype. Our observations do not suggest that variation in the MMP3 gene is causally involved in dementia or AD. (C) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:874 / 881
页数:8
相关论文
共 50 条
  • [41] Dementia and Alzheimer's disease incidence in relationship to cardiovascular disease in the cardiovascular health study cohort
    Newman, AB
    Fitzpatrick, AL
    Lopez, O
    Jackson, S
    Lyketsos, C
    Jagust, W
    Ives, D
    DeKosky, ST
    Kuller, LH
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2005, 53 (07) : 1101 - 1107
  • [42] Insulin metabolism and the risk of Alzheimer disease The Rotterdam Study
    Schrijvers, E. M. C.
    Witteman, J. C. M.
    Sijbrands, E. J. G.
    Hofman, A.
    Koudstaal, P. J.
    Breteler, M. M. B.
    [J]. NEUROLOGY, 2010, 75 (22) : 1982 - 1987
  • [43] Comparing cerebral perfusion in Alzheimer's disease and Parkinson's disease dementia: an ASL-MRI study
    Le Heron, Campbell J.
    Wright, Sarah L.
    Melzer, Tracy R.
    Myall, Daniel J.
    MacAskill, Michael R.
    Livingston, Leslie
    Keenan, Ross J.
    Watts, Richard
    Dalrymple-Alford, John C.
    Anderson, Tim J.
    [J]. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2014, 34 (06) : 964 - 970
  • [44] Association of vitamin D receptor gene haplotypes with late-onset Alzheimer's disease in a Southeastern European Caucasian population
    Dimitrakis, Efthimios
    Katsarou, Martha-Spyridoula
    Lagiou, Maria
    Papastefanopoulou, Vasiliki
    Spandidos, Demetrios A.
    Tsatsakis, Aristidis
    Papageorgiou, Socratis
    Moutsatsou, Paraskevi
    Antoniou, Katerina
    Kroupis, Christos
    Drakoulis, Nikolaos
    [J]. EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2022, 24 (03)
  • [45] Current Treatment Options for Alzheimer's Disease and Parkinson's Disease Dementia
    Szeto, Jennifer Y. Y.
    Lewis, Simon J. G.
    [J]. CURRENT NEUROPHARMACOLOGY, 2016, 14 (04) : 326 - 338
  • [46] Neuropsychiatric differences between Parkinson's disease with dementia and Alzheimer's disease
    Aarsland, D
    Cummings, JL
    Larsen, JP
    [J]. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2001, 16 (02) : 184 - 191
  • [47] Treatment and Management of Dementia Due to Alzheimer’s Disease
    Jennifer Rose V. Molano
    Robin Bratt
    Rhonna Shatz
    [J]. Current Treatment Options in Neurology, 2015, 17
  • [48] Insulin: An Emerging Treatment for Alzheimer's Disease Dementia?
    Morris, Jill K.
    Burns, Jeffrey M.
    [J]. CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2012, 12 (05) : 520 - 527
  • [49] Arylsulphatase A pseudodeficiency in vascular dementia and Alzheimer's disease
    Philpot, M
    Lewis, K
    Pereira, ML
    Ward, C
    Holmes, C
    Lovestone, S
    Fensom, A
    Seller, M
    [J]. NEUROREPORT, 1997, 8 (11) : 2613 - 2616
  • [50] Insulin: An Emerging Treatment for Alzheimer’s Disease Dementia?
    Jill K. Morris
    Jeffrey M. Burns
    [J]. Current Neurology and Neuroscience Reports, 2012, 12 : 520 - 527